[HTML][HTML] S2k-Leitlinie Gastroösophageale Refluxkrankheit und eosinophile Ösophagitis der Deutschen Gesellschaft für Gastroenterologie, Verdauungs-und …

…, G Möller, C Pehl, C Schlag… - Zeitschrift für …, 2023 - thieme-connect.com
Die gastroösophageale Refluxkrankheit gehört zur häufigsten organischen Oberbaucherkrankung.
Zwar hat eine Klasse von Säurehemmern (Protonenpumpeninhibitoren, PPI) seit ca. …

Curriculum for ERCP and endoscopic ultrasound training in Europe: European Society of Gastrointestinal Endoscopy (ESGE) position statement

…, I Boškoski, S Campos, SK Gölder, C Schlag… - …, 2021 - thieme-connect.com
The European Society of Gastrointestinal Endoscopy (ESGE) has recognized the need to
formalize and enhance training in endoscopic retrograde cholangiopancreatography (ERCP) …

[BOOK][B] Zinsderivate: Modelle und Bewertung

N Branger, C Schlag - 2006 - books.google.com
… Die Zahlung der Receiver Swaption in to und damit auch ihr heutiger Wert sind monoton
wachsend in der Strike Rate c. Man sagt nun, dass die Receiver Swaption at-the-money (ATM) …

[HTML][HTML] Endoscopic vacuum therapy in the upper gastrointestinal tract: when and how to use it

CA Gutschow, C Schlag, D Vetter - Langenbeck's Archives of Surgery, 2022 - Springer
Background Endoscopic vacuum therapy (EVT) has emerged as a novel treatment option for
upper gastrointestinal wall defects. The basic principle of action of EVT entails evacuation …

[HTML][HTML] Efficacy of budesonide orodispersible tablets as induction therapy for eosinophilic esophagitis in a randomized placebo-controlled trial

AJ Lucendo, S Miehlke, C Schlag, M Vieth… - Gastroenterology, 2019 - Elsevier
… As achievement of clinical remission (Figure 2A–C) takes longer than achievement of
histologic remission under BOT 1 mg twice daily, the majority of BOT→BOT patients were already …

Internationally cross-listed stock prices during overlapping trading hours: price discovery and exchange rate effects

J Grammig, M Melvin, C Schlag - Journal of Empirical Finance, 2005 - Elsevier
We analyze exchange rates along with equity quotes for 3 German firms from New York (NYSE)
and Frankfurt (XETRA) during overlapping trading hours to see where price discovery …

[HTML][HTML] Budesonide orodispersible tablets maintain remission in a randomized, placebo-controlled trial of patients with eosinophilic esophagitis

…, AJ Lucendo, S Miehlke, M Vieth, C Schlag… - Gastroenterology, 2020 - Elsevier
Background & Aims Eosinophilic esophagitis (EoE) is a chronic inflammatory disorder.
Swallowed topical-acting corticosteroids are effective in bringing active EoE into remission. …

A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis

…, C Bussmann, U von Arnim, M Bajbouj, C Schlag… - Gut, 2016 - gut.bmj.com
Objective To investigate the efficacy and safety of two different budesonide formulations (effervescent
tablet for orodispersible use (BET) and viscous suspension (BVS)) with different …

[HTML][HTML] Treatment of eosinophlic esophagitis with swallowed topical corticosteroids

S Nennstiel, C Schlag - World journal of gastroenterology, 2020 - ncbi.nlm.nih.gov
Eosinophilic esophagitis (EoE) is an emerging chronic local immune-mediated disease of
the esophagus. Beside proton pump inhibitors and food-restriction-diets swallowed topical …

(In)-credibly green: Which bonds trade at a green bond premium?

…, C Latino, C Scheins, C Schlag - Proceedings of Paris …, 2021 - papers.ssrn.com
… and Appendix C of their paper, using their variables and their notation. There are two firms,
C (using … Since in our setting, a firm C produces no negative externalities, the bond's payoff is …